NEW YORK STATE COMMON RETIREMENT FUND - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 96 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$60
-25.9%
5,825
+2.8%
0.00%
Q2 2023$81
-22.1%
5,666
-61.2%
0.00%
Q1 2023$104
-36.6%
14,6030.0%0.00%
Q4 2022$164
-99.9%
14,603
-0.6%
0.00%
Q3 2022$163,000
+32.5%
14,686
+1.0%
0.00%
Q2 2022$123,000
-37.9%
14,536
-0.2%
0.00%
Q1 2022$198,000
-31.0%
14,5690.0%0.00%
Q4 2021$287,000
-38.8%
14,569
-0.3%
0.00%
Q3 2021$469,000
-20.8%
14,617
-16.5%
0.00%
-100.0%
Q2 2021$592,000
+62.6%
17,495
+80.4%
0.00%
Q1 2021$364,000
+13.0%
9,7000.0%0.00%
Q4 2020$322,000
-9.6%
9,7000.0%0.00%
Q3 2020$356,000
+11.6%
9,7000.0%0.00%
Q2 2020$319,000
+27.6%
9,7000.0%0.00%
Q1 2020$250,000
-17.2%
9,7000.0%0.00%
Q4 2019$302,0009,7000.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 5,827,415$187,060,00014.97%
Medicxi Ventures Management (Jersey) Ltd 2,067,861$66,378,00014.44%
Abingworth LLP 1,203,135$38,512,0008.74%
Penn Mutual Asset Management, LLC 86,940$2,791,0004.41%
GREAT POINT PARTNERS LLC 220,863$7,090,0001.65%
RA Capital Management 3,115,008$99,992,0001.39%
StepStone Group LP 422,085$13,549,0000.88%
Summit Rock Advisors, LP 34,100$1,094,0000.65%
Rhenman & Partners Asset Management AB 186,210$5,977,0000.42%
Eventide Asset Management 600,000$19,260,0000.25%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders